Investigation of blood levels of vitamin D in women with breast cancer and its correlation with prognostic markers

authors:

avatar Vahid Semnani , avatar Ensieh Farhidzadeh , avatar majid mirmohammadkhani , avatar Abdolhamid Hajihasani , *

Koomesh: Vol.19, issue 4; 735-741
published online: December 09, 2017
article type: Research Article
received: October 02, 2016
accepted: August 09, 2017

how to cite: Semnani V, Farhidzadeh E, mirmohammadkhani M, Hajihasani A. Investigation of blood levels of vitamin D in women with breast cancer and its correlation with prognostic markers. koomesh. 2017;19(4):e152919. 

Abstract

Introduction: Breast cancer is the most common cancer among women and the second cause of death after lung cancer. Several studies have been conducted to find the better prognosis in patients with breast cancer, which have associated with contradictory results. Current study was done in order to find the relationship between vitamin D and tumor markers and to improve the prognosis of breast cancer patients Materials and Methods: In this cross-sectional descriptive-analytic study, 105 patients referred to oncology clinics of Fatemieh and Kowsar hospitals in Semnan city (Iran) from 2012 to 2016 years were evaluated.  Levels of vitamin D, prognostic markers of breast cancer including estrogen, progesterone, HER-2, P53 and Cyclin D1 receptors and menopause status of patients and also relationship between them were assessed. Results: The results showed that mean of vitamin D was optimal (22.8±9.48) and the maximum frequency of markers related to ER and PR and the minimum one related to HER2. There was not statistically significant relationships between markers and level of vitamin D, but menopausal status and the level of vitamin D had a significant relationship, so that the level of vitamin D in menopausal women was higher than non-menopausal women (p

References

  • 1.

    Fouladi N AF, Harghi AS, Nayebyazdi N. Five year survival of women with breast cancer inArdabil, north-west of Iran. Asian Pac J Cancer Prev 2011; 12: 1799-1801.

  • 2.

    Ghiasvand R ME, Tahmasebi S, Tabatabaee, SH. Risk factors for breast cancer among youngwomen in southern Iran. Int J Cancer 2011; 129: 1443-1449.

  • 3.

    Naieni KH AA, Mahmoodi M, Motevalian, A YY, Yazdizadeh B. Risk factors ofbreast cancer in north of Iran a case-control inMazandaran Province. Asian Pac J Cancer Prev 2007; 8: 395.

  • 4.

    Ameri F, Akbari ME, Abdollahi M, Ajami M, Ajami M, Davoodi SH. Body composition and anthropometric indices in pre- and postmenopausal women with breast cancer. Koomesh 2017; 19: 341-352.

  • 5.

    Anderson BO. Breast healthcare and cancer control in limited-resource countries: a framework for change. Nature Clin Pract Oncol 2006; 3: 4-5.

  • 6.

    Adams S, Gray RJ, Demaria S, Goldstein L, Perez EA, Shulman LN, et al. Prognostic value of tumor-infiltrating lymphocytesin triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199. J Clin Oncol 2014; 32: 2959-2966.

  • 7.

    Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26: v8-v30.

  • 8.

    Yao S, Kwan ML, Ergas IJ, Roh JM, Cheng T-YD, Hong CC, et al. Association of serum level of vitamin D at diagnosis with breast cancer survival: a case-cohort analysis in the pathways study. JAMA Oncol 2017; 3: 351-357.

  • 9.

    Murray A, Madden SF, Synnott NC, Klinger R, O'Connor D, O'Donovan N, et al. Vitamin D receptor as a target for breast cancer therapy. Endoc Relat Cancer 2017; 24: 181-195.

  • 10.

    Bertone-Johnson ER. Vitamin D and breast cancer. Ann Epidemiol 2009; 19: 462-467.

  • 11.

    Shao T, Klein P, Grossbard ML. Vitamin D and breastcancer. The Oncologist 2012; 17: 36-45.

  • 12.

    Anderson LN, Cotterchio M, Vieth R, JA K. Vitamin D and calcium intakes and breast cancer risk in pre- and postmenopausal women. Am J Clin Nutr 2010; 91: 1699-1707.

  • 13.

    Kawase T, Matsuo K, Suzuki T, Hirose K, Hosono S, Watanabe M, et al. Association between vitamin D and calcium intake and breast cancer risk according to menopausal status and receptor status in Japan. Cancer Sci 2010; 101: 1234-1240.

  • 14.

    Chen P, Hu P, Xie D, Qin Y, Wang F, Wang H. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 2010; 121: 469-477.

  • 15.

    Kostoglou-Athanassiou I, Papageorgiou E, Armakolas A, Koutsilieris M. Vitamin D and breast cancer. Endocrine. (Abstracts) 2015; 37. EP1112.

  • 16.

    Gohari MR, Moghadami fard Z, Abolghasemi J, Mohammadi M, Mokhtari p. Prognostic factors of metastases in breast cancer patients using the recurrent Andersen-Gill model. Koomesh 2013; 14: 483-489.

  • 17.

    Naeeni J, Davoodi, Esmaeili. Effects of Vitamin D on risk of breast cancer. Iran J Nutr Sci Food Technol 2013; 7: 53-62. (Persian).

  • 18.

    Yao S, Ambrosone CB. Associations between vitamin D deficiency and risk of aggressive breast cancer in African-American women. J Steroid Biochem Mol Biol 2013; 136: 337-341.

  • 19.

    Probst C, Blcker IM, Mindorf S, Unger M, Fechner K, Meinck HM, et al. Autoantibodies against glycine-associated synaptic proteins in stiff-person syndrome. J Neuroimmunology 2014; 275: 21-22.

  • 20.

    Lemcke S, Sokolowski S, Rieckhoff N, Buschtez M, Kaffka C, WinterKeil A, et al. Automated direct immunofluorescence analyses of skin biopsies. J Cutan Pathol 2016; 43: 227-235.

  • 21.

    Tuohimaa P, Lyakhovich A, Aksenov N, Pennanen P, Syvl H, Lou YR, et al. Vitamin D and prostate cancer. J Steroid Biochem Mol Biol 2001; 76: 125-134.

  • 22.

    Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008; 122: 398-417.

  • 23.

    Yao S1, Zirpoli G, Bovbjerg DH, Jandorf L, Hong CC, Zhao H, et al. Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study. Breast Cancer Res 2012; 14: R58.

  • 24.

    Shirazi L, Almquist M, Borgquist S, Malm J, Manjer J. Serum vitamin D (25OHD3) levels and the risk of different subtypes of breast cancer: A nested case-control study. Breast (Edinburgh, Scotland) 2016; 28: 184-190.

  • 25.

    Eliassen AH, Spiegelman D, Hollis BW, Horst RL, Willett WC, Hankinson SE. Plasma 25-hydroxyvitamin D andrisk of breast cancer in the Nurses' Health Study II. Breast Cancer Res BCR 2011; 13: R50.

  • 26.

    Urata YN, Lyra EC, Katayama ML, Basso RA, Assis PE, Cardoso AP, Roela RA, Nonogaki S, Sampaio Goes JC, Brentani MM, Folgueira MA. Calcitriol supplementation effects on Ki67 expression and transcriptional profile of breast cancer specimens from post-menopausal patients. Clin Nutr 2014; 33: 136-142.

  • 27.

    Zeichner SB, Koru-Sengul T, Shah N, Liu Q, Markward NJ, Montero AJ, et al. Improved clinical outcomes associated with vitamin D supplementation during adjuvant chemotherapy in patients with HER2+ nonmetastatic breast cancer. Clin Breast Cancer 2015; 15: e1-11.

  • 28.

    Ghahremanfard F, Toussy JA, Kazeminezhad B, Ramezani F. Role of cyclooxygenese-2 (COX-2) expression in breast cancer differentiation and its relationship with hormone receptors status. Iran J Pathol 2013; 8. (Persian).

  • 29.

    Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 2003; 100: 8418-8423.

  • 30.

    Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: Serum vitamin D and breast cancer risk. Eur J Cancer 2010; 46: 2196-2205.